Howard, R; Zubko, O; Gray, R; Bradley, R; Harper, E; Kelly, L; Pank, L; ... Nilforooshan, R; + view all Howard, R; Zubko, O; Gray, R; Bradley, R; Harper, E; Kelly, L; Pank, L; O’Brien, J; Fox, C; Tabet, N; Livingston, G; Bentham, P; McShane, R; Burns, A; Ritchie, C; Reeves, S; Lovestone, S; Ballard, C; Noble, W; Wilcock, G; Nilforooshan, R; - view fewer (2020) Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer's disease: the MADE Phase II, three-arm RCT. Efficacy and Mechanism Evaluation , 7 (2) 10.3310/eme07020.